Bis-benzazoles and their use as antineoplastic agents
    1.
    发明授权
    Bis-benzazoles and their use as antineoplastic agents 失效
    双苯并唑及其作为抗肿瘤剂的用途

    公开(公告)号:US06589971B1

    公开(公告)日:2003-07-08

    申请号:US09959084

    申请日:2002-04-18

    IPC分类号: A61K314184

    摘要: “Head-to-head” bis-benzimidazoles having the following formula wherein A1, A2, X1 and X2 are as defined in the following specification, have been found to bind to specific sequences in the minor groove of duplex DNA, and to have cytotoxic effects against a range of tumor cell lines.

    摘要翻译: 具有以下化学式A1,A2,X1和X2的“头 - 头”双苯并咪唑如以下说明书所定义,已经发现与双链DNA的小沟中的特定序列结合并具有细胞毒性作用 针对一系列肿瘤细胞系。

    Nitrate salt of anti-ulcer medicine
    3.
    发明授权
    Nitrate salt of anti-ulcer medicine 失效
    硝酸盐抗溃疡药

    公开(公告)号:US06503929B1

    公开(公告)日:2003-01-07

    申请号:US09622068

    申请日:2000-08-29

    申请人: Piero Del Soldato

    发明人: Piero Del Soldato

    IPC分类号: A61K314184

    摘要: Nitrate salt compositions with anti-ulcer medicines having formula (A) and (B) wherein the (A) class compounds: R=H, OCH3, OCHF2; R1=CH3, OCH3; R2=H, CH3; R3=CH3, CH2—CF3, (CH2)3—OCH3; wherein the (B) class compounds: RI3, RI4 equal to or different from each other, are respectively free valence hydrogen, (1), —CH2—N(CH3)2; Y=S, N—RI6, CRI7RI8; X=O, S, N—RI1; RI2=H, CH3; n=0, 1; Z=N—CN, N—SO2NH2, CH—NO2 or formula (VIIA) RI5=H, —NH—CH3, NH2; RI6, RI7, RI8, RI1, equal to or different from each other, are hydrogen, free valence. The invention also comprises the methods for the preparation of above salts.

    摘要翻译: 具有式(A)和(B)的抗溃疡药的硝酸盐组合物,其中(A)类化合物:R = H,OCH 3,OCHF 2; R1 = CH3,OCH3; R2 = H,CH3; R3 = CH3,CH2-CF3,(CH2)3-OCH3; 其中(B)类化合物:RI3,RI4彼此相同或不同,分别为游离价氢,(1),-CH 2 -N(CH 3)2; Y = S,N-RI6,CRI7RI8; X = O,S,N-RI1; RI2 = H,CH3; n = 0,1; Z = N-CN,N-SO 2 NH 2,CH-NO 2或式(VIIA)R 5 = H,-NH-CH 3,NH 2; RI6,RI7,RI8,RI1,相同或不同,为氢,游离价。 本发明还包括制备上述盐的方法。

    Benzimidazoles with antithrombotic activity
    5.
    发明授权
    Benzimidazoles with antithrombotic activity 有权
    具有抗血栓活性的苯并咪唑

    公开(公告)号:US06451832B2

    公开(公告)日:2002-09-17

    申请号:US09735159

    申请日:2000-12-12

    IPC分类号: A61K314184

    摘要: Novel benzimidazoles having antithrombotic activity. Exemplary are: (a) 2-(4-amidinophenylaminomethyl)-1-methyl-5-[1-(ethoxycarbonylmethylamino)-1-(2,5-dihydropyrrolocarbonyl)-ethyl]-benzimidazole, (b) 2-[4-(N-phenylcarbonylamidino)-phenylaminomethyl]-1-methyl-5-[1-(ethoxycarbonylmethylamino)-1-(2,5-dihydropyrrolocarbonyl)-ethyl]-benzimidazole, and (c) (R)-2-[4-(N-phenylcarbonylamidino)-phenylaminomethyl]-1-methyl-5-[1-(isobutyloxycarbonylmethylamino)-1-(pyrrolidinocarbonyl)-ethyl]-benzimidazole.

    摘要翻译: 具有抗血栓活性的新型苯并咪唑。 示例性的是:(a)2-(4-脒基苯基氨基甲基)-1-甲基-5- [1-(乙氧基羰基甲基氨基)-1-(2,5-二氢吡咯羰基) - 乙基] - 苯并咪唑,(b)2- [4- (N-苯基羰基脒基) - 苯基氨基甲基] -1-甲基-5- [1-(乙氧基羰基甲基氨基)-1-(2,5-二氢吡咯羰基) - 乙基] - 苯并咪唑,和(c)(R)-2- [4- (N-苯基羰基脒基) - 苯基氨基甲基] -1-甲基-5- [1-(异丁氧基羰基甲基氨基)-1-(吡咯烷基羰基) - 乙基] - 苯并咪唑。

    Amide derivatives and medicinal compositions thereof
    7.
    发明授权
    Amide derivatives and medicinal compositions thereof 失效
    酰胺衍生物及其药用组合物

    公开(公告)号:US06177454B1

    公开(公告)日:2001-01-23

    申请号:US09514637

    申请日:2000-02-29

    IPC分类号: A61K314184

    摘要: An amide derivative represented by the following general formula (I) or a salt thereof and a pharmaceutical composition containing the amide derivative and a pharmaceutically acceptable vehicle. The symbols in the formula have the following meanings wherein A: heteroarylene; X: bond, O, S, —NR5—, —NR5CO—, —NR5CONH—, —NR5SO2— or —NR5C(═NH)NH—; R1: —H, -optionally substituted lower alkyl, -optionally substituted aryl, -optionally substituted heteroaryl or -optionally substituted cycloalkyl; R2a, R2b: —H or -lower alkyl, which may be the same or different; R3: —H or -lower alkyl; R4a, R4b: —H or —OH, which may be the same different, or R4a and R4b are taken together to form ═O or ═N—O—lower alkyl; and R5: —H or -lower alkyl.

    摘要翻译: 由以下通式(I)表示的酰胺衍生物或其盐和含有酰胺衍生物和药学上可接受的载体的药物组合物。式中的符号具有以下含义:A:亚杂芳基; X:键,O,S, -NR5-,-NR5CO-,-NR5CONH-,-NR5SO2-或-NR5C(= NH)NH-; R1:-H,可选取代的低级烷基, - 取代的芳基, - 取代的杂芳基或 - 取代的环烷基 ; R 2a,R 2b:-H或 - 低级烷基,其可以相同或不同; R 3:-H或 - 低级烷基; R 4a,R 4b:-H或-OH,其可以相同,或者R 4a和R 4b 一起形成= O或= NO-低级烷基; 和R5:-H或 - 低级烷基。

    Spiro imidazoline compounds
    8.
    发明授权
    Spiro imidazoline compounds 失效
    螺咪唑啉化合物

    公开(公告)号:US06172097B2

    公开(公告)日:2001-01-09

    申请号:US09465619

    申请日:1999-12-17

    IPC分类号: A61K314184

    CPC分类号: C07D235/02

    摘要: The invention relates to a compound of formula (I): wherein: A represents an optionally substituted benzene ring, B represents an imidazoline ring of formula (Ia) or (Ib): and medicinal products containing the same/are useful in treating or in preventing depression, obesity, panic attacks, anxiety, obsessive-compulsive disorders, cognitive disorders, phobias, impulsive disorders associated with the abuse of drugs and withdrawal therefrom, sexual dysfunctions, and Parkinson's disease.

    摘要翻译: 本发明涉及式(I)化合物:其中:A表示任选取代的苯环,B表示式(Ia)或(Ib)的咪唑啉环:和含有该化合物的药物,可用于治疗或 预防抑郁症,肥胖症,惊恐发作,焦虑症,强迫症,认知障碍,恐怖症,与药物滥用相关的冲动性疾病和从其中退出,性功能障碍和帕金森病。